cis-1-(tert-Butoxycarbonyl)pyrrolidine-3,4-dicarboxylic acid

Catalog No. :
ACTEFU875
CAS No. :
441298-21-1
Molecular Formula :
C11H17NO6
Molecular Weight :
259.26

IUPAC Name:(3R,4S)-1-(tert-butoxycarbonyl)pyrrolidine-3,4-dicarboxylic acid

cis-1-(tert-Butoxycarbonyl)pyrrolidine-3,4-dicarboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$143.00Login to see priceInquiryInquiry
100mg95%$209.00Login to see priceInquiryInquiry
250mg95%$293.00Login to see priceInquiryInquiry
1g95%$584.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Namecis-1-(tert-Butoxycarbonyl)pyrrolidine-3,4-dicarboxylic acid
IUPAC Name(3R,4S)-1-(tert-butoxycarbonyl)pyrrolidine-3,4-dicarboxylic acid
MDL No.MFCD15071833
Molecular FormulaC11H17NO6
Molecular Weight259.26
SMILESO=C([C@H]1CN(C(OC(C)(C)C)=O)C[C@H]1C(O)=O)O
InChI KeyCEWHNBGJGPXFED-KNVOCYPGSA-N
Synonymcis-N-Boc-pyrrolidine-3,4-dicarboxylic acid;cis-1-(tert-butoxycarbonyl)pyrrolidine-3,4-dicarboxylic acid;(3S,4R)-1-(tert-butoxycarbonyl)pyrrolidine-3,4-dicarboxylic acid
CAS No.441298-21-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACTEFU875 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTEFU875 route product structure diagram
    ACTEFU875441298-21-1
Inquiry

2. ACTEFU875 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTEFU875 route product structure diagram
    ACTEFU875441298-21-1
Inquiry

Comments (0)